DE3671372D1 - Etoposid-praeparate. - Google Patents

Etoposid-praeparate.

Info

Publication number: DE3671372D1
Authority: DE; Germany
Prior art keywords: etoposid; preparations; etoposid preparations
Prior art date: 1985-02-19
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Expired - Lifetime

Application number

DE8686300642T

Other languages

English (en)

Inventor

Takashi Terada

Hideyuki Ishimado

Masaru Suzuki

Minoru Nakada

Gen Iti Idzu

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

Nippon Kayaku Co Ltd

Original Assignee

Nippon Kayaku Co Ltd

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1985-02-19

Filing date

1986-01-30

Publication date

1990-06-28

1986-01-30 Application filed by Nippon Kayaku Co Ltd filed Critical Nippon Kayaku Co Ltd

1990-06-28 Application granted granted Critical

1990-06-28 Publication of DE3671372D1 publication Critical patent/DE3671372D1/de

2006-01-31 Anticipated expiration legal-status Critical

Status Expired - Lifetime legal-status Critical Current

Links

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4858—Organic compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/4841—Filling excipients; Inactive ingredients
- A61K9/4866—Organic macromolecular compounds
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents

DE8686300642T 1985-02-19 1986-01-30 Etoposid-praeparate. Expired - Lifetime DE3671372D1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
JP60031203A JPS61189230A (ja)	1985-02-19	1985-02-19	エトポシド製剤

Publications (1)

Publication Number	Publication Date
DE3671372D1 true DE3671372D1 (de)	1990-06-28

Family

ID=12324856

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DE8686300642T Expired - Lifetime DE3671372D1 (de)	1985-02-19	1986-01-30	Etoposid-praeparate.

Country Status (10)

Country	Link
US (1)	US4734284A (de)
EP (1)	EP0193287B1 (de)
JP (1)	JPS61189230A (de)
KR (1)	KR920003332B1 (de)
AU (1)	AU583585B2 (de)
DE (1)	DE3671372D1 (de)
DK (1)	DK165902C (de)
ES (1)	ES8704727A1 (de)
HU (1)	HU196707B (de)
MX (1)	MX9202976A (de)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4940701A (en) *	1984-01-25	1990-07-10	Beecham Group P.L.C.	Topical drug release system
GB8629639D0 (en) *	1986-12-11	1987-01-21	Beecham Group Plc	Composition & method
US4927638A (en) *	1986-10-08	1990-05-22	Bristol-Myers Company	Etoposide solutions
US4772589A (en) *	1986-10-29	1988-09-20	Bristol-Myers	Etoposide solution in NMP
GB8629640D0 (en) *	1986-12-11	1987-01-21	Beecham Group Plc	Composition & method
CA2017916C (en) *	1989-06-07	1999-02-02	Minoru Aoki	Etoposide preparations
US5141961A (en) *	1991-06-27	1992-08-25	Richrdson-Vicks Inc.	Process for solubilizing difficulty soluble pharmaceutical actives
US5447936A (en) *	1993-12-22	1995-09-05	Bionumerik Pharmaceuticals, Inc.	Lactone stable formulation of 10-hydroxy 7-ethyl camptothecin and methods for uses thereof
US5468754A (en) *	1994-04-19	1995-11-21	Bionumerik Pharmaceuticals, Inc.	11,7 substituted camptothecin derivatives and formulations of 11,7 substituted camptothecin derivatives and methods for uses thereof
US5604233A (en) *	1994-04-28	1997-02-18	Bionumerik Pharmaceuticals, Inc.	Lactone stable formulation of 7-ethyl camptothecin and methods for uses thereof
US5919481A (en) *	1996-06-28	1999-07-06	Ncneil-Ppc, Inc.	Fill material for soft gelatin pharmaceutical dosage form
US6024980A (en) *	1996-06-28	2000-02-15	Mcneil-Ppc, Inc.	Multiphase soft gelatin dosage form
US7919109B2 (en)	1999-02-08	2011-04-05	Intarcia Therapeutics, Inc.	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicles
ES2379471T5 (es) *	1999-02-08	2015-05-26	Intarcia Therapeutics, Inc	Vehículos viscosos biocompatibles de fase única no acuosos y procedimientos para su preparación
US7258869B1 (en)	1999-02-08	2007-08-21	Alza Corporation	Stable non-aqueous single phase viscous vehicles and formulations utilizing such vehicle
AU2001232344A1 (en) *	2000-02-21	2001-08-27	Fujisawa Pharmaceutical Co. Ltd.	Liquid preparation with improved absorbability
DE60319355T3 (de)	2002-04-25	2012-01-05	Banner Pharmacaps Inc.	Kaubare weichkapsel
US7731947B2 (en)	2003-11-17	2010-06-08	Intarcia Therapeutics, Inc.	Composition and dosage form comprising an interferon particle formulation and suspending vehicle
US20050220866A1 (en) *	2004-04-02	2005-10-06	Dr. Reddy's Laboratories Limited	Novel capsule formulations of etoposide for oral use
WO2006083761A2 (en)	2005-02-03	2006-08-10	Alza Corporation	Solvent/polymer solutions as suspension vehicles
US11246913B2 (en)	2005-02-03	2022-02-15	Intarcia Therapeutics, Inc.	Suspension formulation comprising an insulinotropic peptide
MX2008014870A (es)	2006-05-30	2009-02-12	Intarcia Therapeutics Inc	Modulador de flujo para sistema de suministro osmotico con canal interno de dos piezas.
EP3421031A1 (de)	2006-08-09	2019-01-02	Intarcia Therapeutics, Inc	Osmotisches verabreichungssystem mit kolbenanordnung
CN101715340A (zh)	2007-04-23	2010-05-26	精达制药公司	促胰岛素释放肽的混悬制剂及其应用
EP2240155B1 (de)	2008-02-13	2012-06-06	Intarcia Therapeutics, Inc	Vorrichtungen, formulierungen und verfahren zur freisetzung mehrerer wirkstoffe
SI2462246T1 (en)	2009-09-28	2018-01-31	Intarcia Therapeutics, Inc.	Fast-setting and / or cessation of substantially unchanged delivery of the product
US20120208755A1 (en)	2011-02-16	2012-08-16	Intarcia Therapeutics, Inc.	Compositions, Devices and Methods of Use Thereof for the Treatment of Cancers
US9889085B1 (en)	2014-09-30	2018-02-13	Intarcia Therapeutics, Inc.	Therapeutic methods for the treatment of diabetes and related conditions for patients with high baseline HbA1c
KR102650751B1 (ko)	2015-06-03	2024-03-22	인타르시아 세라퓨틱스 인코포레이티드	임플란트 배치 및 제거 시스템들
SG10201913699QA (en)	2016-05-16	2020-03-30	Intarcia Therapeutics Inc	Glucagon-receptor selective polypeptides and methods of use thereof
USD840030S1 (en)	2016-06-02	2019-02-05	Intarcia Therapeutics, Inc.	Implant placement guide
USD860451S1 (en)	2016-06-02	2019-09-17	Intarcia Therapeutics, Inc.	Implant removal tool
AU2018206539A1 (en)	2017-01-03	2019-07-18	Intarcia Therapeutics, Inc.	Methods comprising continuous administration of a GLP-1 receptor agonist and co-administration of a drug
US20200338082A1 (en) *	2017-12-28	2020-10-29	Scott ACKLER	Formulations, systems, and methods for therapeutic treatment
WO2023220641A2 (en)	2022-05-11	2023-11-16	Juno Therapeutics, Inc.	Methods and uses related to t cell therapy and production of same

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CH514578A (de) *	1968-02-27	1971-10-31	Sandoz Ag	Verfahren zur Herstellung von Glucosiden
ZA728764B (en) *	1971-12-29	1973-08-29	Squibb & Sons Inc	One piece gelatin capsules containing chloral hydrate
JPS5885813A (ja) *	1981-11-17	1983-05-23	Toyo Jozo Co Ltd	吸収性良好な製剤
DE3250023T (de) *	1981-01-14	1990-03-29
JPS6032799A (ja) *	1983-07-29	1985-02-19	Microbial Chem Res Found	新規４′−デメチル−４−エピポドフィロトキシン誘導体
NZ211078A (en) *	1984-03-19	1987-08-31	Bristol Myers Co	Oral dosage form of etoposide
JPS60239418A (ja) *	1984-05-15	1985-11-28	Nippon Kayaku Co Ltd	エトポシド軟カプセル製剤
US4609644A (en) *	1984-06-15	1986-09-02	St. Jude Children's Research Hospital	Epipodophyllotoxinquinone glucoside derivatives, method of production and use

1985
- 1985-02-19 JP JP60031203A patent/JPS61189230A/ja active Granted
1986
- 1986-01-28 US US06/823,362 patent/US4734284A/en not_active Expired - Lifetime
- 1986-01-29 AU AU52793/86A patent/AU583585B2/en not_active Expired
- 1986-01-30 DE DE8686300642T patent/DE3671372D1/de not_active Expired - Lifetime
- 1986-01-30 EP EP86300642A patent/EP0193287B1/de not_active Expired - Lifetime
- 1986-02-03 KR KR1019860000713A patent/KR920003332B1/ko not_active IP Right Cessation
- 1986-02-17 ES ES552067A patent/ES8704727A1/es not_active Expired
- 1986-02-18 DK DK075886A patent/DK165902C/da not_active IP Right Cessation
- 1986-02-18 HU HU86679A patent/HU196707B/hu unknown
1992
- 1992-06-18 MX MX9202976A patent/MX9202976A/es unknown

Also Published As

Publication number	Publication date
AU5279386A (en)	1986-08-28
KR920003332B1 (ko)	1992-04-27
DK75886D0 (da)	1986-02-18
DK75886A (da)	1986-08-20
DK165902C (da)	1993-06-28
MX9202976A (es)	1992-07-01
ES8704727A1 (es)	1987-04-16
EP0193287A3 (en)	1986-10-08
ES552067A0 (es)	1987-04-16
HU196707B (en)	1989-01-30
KR860006263A (ko)	1986-09-09
DK165902B (da)	1993-02-08
AU583585B2 (en)	1989-05-04
EP0193287B1 (de)	1990-05-23
US4734284A (en)	1988-03-29
HUT43953A (en)	1988-01-28
JPS6366810B2 (de)	1988-12-22
JPS61189230A (ja)	1986-08-22
EP0193287A2 (de)	1986-09-03

Legal Events

Date	Code	Title	Description
1991-06-20	8364	No opposition during term of opposition

Publication	Publication Date	Title
DE3671372D1 (de)	1990-06-28	Etoposid-praeparate.
DE3686172T2 (de)	1993-01-14	Peptid-derivate.
ATE77088T1 (de)	1992-06-15	8-phenylxanthine.
FI861722A0 (fi)	1986-04-24	Flockulationsprocess.
ATE55980T1 (de)	1990-09-15	2-hydroxy-3-phenoxypropylamine.
FI870638A0 (fi)	1987-02-16	Uppvaermningsapparat foer under tryck staoende oeverfoeringsvaetska.
DE3766958D1 (de)	1991-02-07	Isochinolin-derivate.
DE3668776D1 (de)	1990-03-15	Endotubus.
ATE50243T1 (de)	1990-02-15	Fluorbenzylester.
DE3683474D1 (de)	1992-02-27	Numerisierungsverfahren.
NO863532L (no)	1986-09-03	Skjoeteboks.
DE3671606D1 (de)	1990-07-05	Sichter.
NO863500D0 (no)	1986-09-02	Undervannsfartoey.
DK133786D0 (da)	1986-03-21	Praeparater
NO862439L (no)	1986-06-18	Farmasoeytiske preparater.
NO874193D0 (no)	1987-10-06	Farmasoeytiske preparater.
DK24986D0 (da)	1986-01-17	Praeparater
DE3675679D1 (de)	1991-01-03	Menschliche bauchspeichelelastase.
DE3682446D1 (de)	1991-12-19	Isochinolinderivate.
NO864034D0 (no)	1986-10-10	Fungicide preparater.
FR2600889B1 (fr)	1989-12-15	Preparations veterinaires.
DE3681759D1 (de)	1991-11-07	Abschreckverfahren.
DK503386D0 (da)	1986-10-20	Peptidpraeparater
DE3667938D1 (de)	1990-02-08	Raederfalzapparat.
DK466086A (da)	1987-04-09	Exogent syrnede antacidiumpraeparater